Description
Harvoni (Sofosbuvir 400 mg + Ledipasvir 90 mg) was originally designed to treat Hep C genotype 1. It is generally considered the most effective treatment for Hepatitis C genotype 1.
Harvoni is not the optimum treatment for any other form of Hep C.